Fig. 3
From: Multi-omics integration for neuroblastoma clinical endpoint prediction
Integration evaluation. Distribution of ΔMCC values in cross-validation (panels a, c, e, g) and in validation (panels b, d, f, h) stratified by classifier (a, b) and endpoint (c–h). Panels c, d: AG1-G/MAV-G on the 498 data subset. Panels e, f: AG1-G/CNV-G. Panels g, h: MAV-G/CNV-G